Medical Condition News

RSS

Mayo Clinic releases new app to help fight anxiety

Mayo Clinic is releasing an app this week for Apple iPhones, iPads and iPod Touch called Anxiety Coach, a self-help tool that assists people in reducing a variety of fears and worries ranging from extreme shyness to obsessions and compulsions.

4 Oct 2012

New type of drug for drug-resistant cancer

New drug may be an effective alternative for patients whose cancer is resistant to currently available drugs.

4 Oct 2012

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.

4 Oct 2012

Simple new test can monitor treatment of eosinophilic esophagitis

A simple new test, in which the patient swallows a string, can monitor treatment of eosinophilic esophagitis as effectively as an invasive, expensive and uncomfortable procedure that risks complications, particularly in children.

4 Oct 2012

Novel technology can identify potential biomarkers of ulcerative colitis

Scientists from the Florida campus of The Scripps Research Institute have developed a novel technology that can identify, in animal models, potential biomarkers of ulcerative colitis, a type of inflammatory bowel disease that affects the lining of the colon.

4 Oct 2012

Stereocilia not only move sideways but also change in length: Study

The sensory cells of the inner ear have tiny hairs called stereocilia that play a critical part in hearing. It has long been known that these stereocilia move sideways back and forth in a wave-like motion when stimulated by a sound wave. After having designed a microscope to observe these movements, a research team at Karolinska Institutet in Sweden has discovered that the hairs not only move sideways but also change in length.

4 Oct 2012

New nanodevice lays foundations for future development of novel therapies against aging

A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.

4 Oct 2012

New spontaneous genetic mutations play a significant role in schizophrenia

Columbia University Medical Center (CUMC) researchers have identified dozens of new spontaneous genetic mutations that play a significant role in the development of schizophrenia, adding to the growing list of genetic variants that can contribute to the disease.

4 Oct 2012

Bristol-Myers Squibb, Sanofi restructure long-term alliance

Sanofi and Bristol-Myers Squibb Company today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets.

4 Oct 2012

Georgia Tech's ClockMe system helps older adults identify early signs of dementia

With baby boomers approaching the age of 65 and new cases of Alzheimer's disease expected to increase by 50 percent by the year 2030, Georgia Tech researchers have created a tool that allows adults to screen themselves for early signs of dementia. The home-based computer software is patterned after the paper-and-pencil Clock Drawing Test, one of health care's most commonly used screening exams for cognitive impairment.

4 Oct 2012

Assisted reproduction technology may increase risk of MS activity among women

Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.

4 Oct 2012

Positive data from three Onconova Ex-RAD clinical trials on acute radiation syndrome

Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD (recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).

4 Oct 2012

Lecture to discuss insights into genes and neurodegenerative diseases gleaned from baker's yeast

Insights into our genes and neurodegenerative diseases gleaned from humble baker's yeast, among other things, will be showcased by genetics experts at a free public lecture.

4 Oct 2012

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

XBiotech, a privately held biotechnology company, announced today that the company has been granted Fast Track designation for its anti-cachexia drug Xilonix.

4 Oct 2012

Merck announces data from MK-3102 Phase IIb trial on type 2 diabetes

Merck, known as MSD outside the United States and Canada, today announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

4 Oct 2012

Gateway Foundation to raise awareness of synthetic drug use

In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.

4 Oct 2012

Treatment with Lfcin4-14 reduces DNA damage in colon cancer cells exposed to UV light

Milk consumption has been linked to improved health, with decreased risks of diabetes, metabolic syndrome, and colon cancer. A group of scientists in Sweden found that lactoferricin4-14 (Lfcin4-14), a milk protein with known health effects, significantly reduces the growth rate of colon cancer cells over time by prolonging the period of the cell cycle before chromosomes are replicated. In a new study, investigators report that treatment with Lfcin4-14 reduced DNA damage in colon cancer cells exposed to ultraviolet (UV) light.

4 Oct 2012

Study finds significant variation in overall health of all major Latino subgroups in the U.S.

Despite a shared Latino heritage, there are significant differences in the overall health and the use of health-care services among Cuban-Americans, Mexican-Americans and Puerto Rican-Americans - even between men and women in the same subgroup - according to two recently published studies by Florida State University researchers.

4 Oct 2012

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

What's the latest, research-supported best practice in periodontal care and implant dentistry? Dental specialists and generalists alike can read about it in the first of a new series from The Journal of Evidence-Based Dental Practice (JEBDP), the foremost publication of information about evidence-based dental practice, published by Elsevier.

4 Oct 2012

ADA, Wiley partner to publish latest book in ‘Practical Guide Series’

John Wiley & Sons, Inc., recently announced a collaboration with the American Dental Association (ADA) to publish the latest book in their "Practical Guide Series," The ADA Practical Guide to Patients with Medical Conditions.

4 Oct 2012

Medical Condition News

Mayo Clinic releases new app to help fight anxiety

New type of drug for drug-resistant cancer

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Simple new test can monitor treatment of eosinophilic esophagitis

Novel technology can identify potential biomarkers of ulcerative colitis

Stereocilia not only move sideways but also change in length: Study

New nanodevice lays foundations for future development of novel therapies against aging

New spontaneous genetic mutations play a significant role in schizophrenia

Bristol-Myers Squibb, Sanofi restructure long-term alliance

Georgia Tech's ClockMe system helps older adults identify early signs of dementia

Assisted reproduction technology may increase risk of MS activity among women

Positive data from three Onconova Ex-RAD clinical trials on acute radiation syndrome

Lecture to discuss insights into genes and neurodegenerative diseases gleaned from baker's yeast

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

Merck announces data from MK-3102 Phase IIb trial on type 2 diabetes

Gateway Foundation to raise awareness of synthetic drug use

Treatment with Lfcin4-14 reduces DNA damage in colon cancer cells exposed to UV light

Study finds significant variation in overall health of all major Latino subgroups in the U.S.

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

ADA, Wiley partner to publish latest book in ‘Practical Guide Series’

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News